Risk factors for nosocomial candidaemia: a case-control study in children

Edwards, 1978, Severe candidal infections. Clinical perspective, immune defense mechanisms and current concepts of therapy, Ann Intern Med, 89, 91, 10.7326/0003-4819-89-1-91 Wey, 1989, Risk factors for hospital-acquired candidaemia. A matched case-control study, Arch Intern Med, 149, 2349, 10.1001/archinte.1989.00390100145030 Rose, 1978, Venous catheter associated candidaemia, Am J Med Sci, 275, 265, 10.1097/00000441-197805000-00004 Stamos, 1995, Candidaemia in a Pediatric population, Clin Infect Dis, 20, 571, 10.1093/clinids/20.3.571 Bross, 1989, Risk factors for nosocomial candidemia: A case-control study in adults without leukemia, Am J Med, 87, 614, 10.1016/S0002-9343(89)80392-4 Karabinis, 1988, Risk factors for candidemia in cancer patients: a case-control study, J Clin Microbiol, 87, 614 Tollemar, 1989, Variables predicting deep fungal infections in bone marrow transplant recipients, Bone Marrow Transplant, 4, 635 Richet, 1991, Risk factors for candidemia in patients with acute lymphocytic leukemia, Rev Infect Dis, 13, 211, 10.1093/clinids/13.2.211 Mac Donald, 1998, Risk factors for candidemia in a children's hospital, Clin Infect Dis, 26, 642, 10.1086/514580 Kwon-Chung, 1992 Pfaller, 1994, Epidemiology and control of fungal infections, Clin Infect Dis, 19, S8, 10.1093/clinids/19.Supplement_1.S8 Horn, 1985, Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy, Rev Infect Dis, 7, 646, 10.1093/clinids/7.5.646 Jarvis, 1991, Nosocomial infection rates in adult and pediatric intensive care units in the United States, Am J Med, 91, 86S, 10.1016/0002-9343(91)90367-7 Faix, 1992, Invasive neonatal candidiasis: comparison of albicans and parapsilosis infection, Pediatr Infect Dis J, 11, 88, 10.1097/00006454-199202000-00006 Pfaller, 1996, Nosocomial candidiasis: emerging species, reservoirs and modes of transmission, Clin Infect Dis, 22, S89, 10.1093/clinids/22.Supplement_2.S89 Pfaller, 1995, Epidemiology and control of fungal infections, Clin Infect Dis, 30, 329 Pfaller, 2000, Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997–1998, Antimicrob Agent Chemother, 44, 747, 10.1128/AAC.44.3.747-751.2000 Jarvis, 1995, Epidemiology of nosocomial fungal infections, with emphasis on Candida species, Clin Infect Dis, 20, 1526, 10.1093/clinids/20.6.1526 Wingard, 1995, Importance of Candida species other than C. albicans as pathogens in oncology patients, Clin Infect Dis, 20, 115, 10.1093/clinids/20.1.115 Rex, 1995, Antifungal susceptibility testing of isolates from a randomized multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidaemia, Antimicrob Agents Chemother, 39, 40, 10.1128/AAC.39.1.40 Harvey, 1987, Nosocomial fungemia in a large community teaching hospital, Arch Intern Med, 147, 2117, 10.1001/archinte.1987.00370120053011 Solomon, 1986, Nosocomial fungemia in neonates associated with intravascular pressure-monitoring devices, Pediatr Infect Dis, 5, 680, 10.1097/00006454-198611000-00016 Weese-Mayer, 1987, Risk factors associated with candidaemia in the neonatal intensive care unit: a case-control study, Pediatr Infect Dis, 6, 190, 10.1097/00006454-198702000-00009 Weems, 1992, Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility, Clin Infect Dis, 14, 756, 10.1093/clinids/14.3.756 Rotrosen, 1986, Adherence of Candida species to host tissues and plastic services, Rev Infect Dis, 8, 73, 10.1093/clinids/8.1.73